S-Space: Seoul National University
metadata only
From undruggable to degradable: Strategic expansion of targeted protein degradation in cancer therapy
Targeted protein degradation (TPD) has reshaped modern pharmacology by shifting therapeutic strategies from occupancy-driven inhibition toward event-driven elimination of disease-causing proteins, including targets long regarded as undruggable. Beyond canonical modalities such as proteolysis-targeti
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunities.#242334
- Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer#883263
- Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer#883934
- Translation dysregulation in cancer as a source for targetable antigens.#174582
- Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer#913274
Record · ID 1081840
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive